Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.37 |
| ▸ | MAOB | P27338 | 5/20 | 0.37 |
| ▸ | APP | P05067 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 6/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764546 | 1.00 | MAOA (0.37) | MAOAMAOBAPPKDM4EBCHE | |
| SCHEMBL9764323 | 0.88 | MAOB (0.40) | MAOAMAOBAPPBCHEACHE | |
| SCHEMBL9764330 | 0.88 | MAOB (0.40) | MAOAMAOBAPPBCHEACHE | |
| SCHEMBL9764430 | 0.85 | KCNH2 (0.44) | — | |
| SCHEMBL9764436 | 0.85 | KCNH2 (0.44) | — | |
| SCHEMBL9764504 | 0.83 | SLC2A1 (0.33) | MAOAMAOBAPPKDM4ENR1H3 | |
| SCHEMBL9764500 | 0.83 | SLC2A1 (0.33) | MAOAMAOBAPPKDM4ENR1H3 | |
| SCHEMBL10417921 | 0.81 | SLC2A1 (0.37) | MAOAMAOBAPPKDM4ENR1H3 | |
| SCHEMBL10417920 | 0.81 | SLC2A1 (0.37) | MAOAMAOBAPPKDM4ENR1H3 | |
| SCHEMBL10390476 | 0.79 | BCHE (0.46) | MAOAMAOBBCHEACHENR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5006556-A | Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction | GLAXO GROUP LIMITED (GB) | 1991-04-09 | — | — | US | disclosed |
| US-4943591-A | TREATMENT OF ASTHMA AND BRONCHITIS | GLAXO GROUP LIMITED (GB) | 1990-07-24 | — | — | US | disclosed |